4FRONT-1 - 4D-150-C003 - Clinical Trial
What is the Purpose of this Study?
People in this study will be part of it for about 110 weeks, which is a little more than 2 years. During that time, they will need to visit the study clinic at least 30 times. At each visit, they will have tests and check-ups that are part of their regular care and also for the study.
Macular Neovascularization Secondary to Age-Related Macular Degeneration (wet AMD)
Who Can Participate in the Study?
People in this study must:
- Be 50 years old or older.
- Have never had treatment for their eye condition before.
- Have never had a problem called retinal detachment, which is when part of the eye pulls away from where it should be.
What is Involved?
This study is trying to find out how well a new medicine called 4D-150 works compared to a medicine called Eylea in adults who have a kind of eye disease called wet age-related macular degeneration (wet AMD). The medicine is given as a shot directly into the eye. The study also wants to make sure the new medicine is safe and lasts a long time.
Study Details
